Phase 2 Trial of Total Mucosal and Bilateral Neck Intensity Modulated Radiotherapy in Squamous Cell Cancer of Unknown Primary

被引：2
|
作者：
Richards, T. M. [1 ]
Bhide, S. A. [1 ]
Miah, A. B. [1 ]
Schick, U. [1 ]
Gujral, D. M. [1 ]
Newbold, K. [1 ]
Harrington, K. J. [1 ]
Nutting, C. M. [1 ]
机构：
[1] Royal Marsden Hosp, Head & Neck Unit, London SW3 6JJ, England
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72194-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S559 / S559
页数：1
相关论文
共 50 条
  • [41] Larynx-sparing radiotherapy for squamous cell carcinoma from an unknown head and neck primary site
    Barker, CA
    Morris, CG
    Mendenhall, WM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (05): : 445 - 448
  • [42] A phase II trial of docetaxel in squamous cell cancer of the head and neck
    Posner, M
    Dreyfuss, A
    Norris, C
    Costello, R
    Rossi, R
    Poulin, M
    Clark, J
    Busse, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 421 - 421
  • [43] Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
    Espeli, V.
    Zucca, E.
    Ghielmini, M.
    Giannini, O.
    Salatino, A.
    Martucci, F.
    Richetti, A.
    ORAL ONCOLOGY, 2012, 48 (03) : 266 - 271
  • [44] INTENSITY-MODULATED RADIOTHERAPY FOR CERVICAL NODE SQUAMOUS CELL CARCINOMA METASTASES FROM UNKNOWN HEAD-AND-NECK PRIMARY SITE: M. D. ANDERSON CANCER CENTER OUTCOMES AND PATTERNS OF FAILURE
    Frank, Steven J.
    Rosenthal, David I.
    Petsuksiri, Janjira
    Ang, K. Kian
    Morrison, William H.
    Weber, Randal S.
    Glisson, Bonnie S.
    Chao, K. S. Clifford
    Schwartz, David L.
    Chronowski, Gregory M.
    El-Naggar, Adel K.
    Garden, Adam S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (04): : 1005 - 1010
  • [45] Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma A Nonrandomized Controlled Trial
    Saba, Nabil F.
    Wong, Stuart J.
    Nasti, Tahseen
    McCook-Veal, Ashley Alesia
    Mcdonald, Mark W.
    Stokes, William A.
    Anderson, Allyson M.
    Ekpenyong, Asari
    Rupji, Manali
    Abousaud, Marin
    Rudra, Soumon
    Bates, James E.
    Remick, Jill S.
    Joshi, Nikhil P.
    Woody, Neil M.
    Awan, Musaddiq
    Geiger, Jessica L.
    Shreenivas, Aditya
    Samsa, Julia
    Ward, Matthew Christopher
    Schmitt, Nicole C.
    Patel, Mihir R.
    Higgins, Kristin A.
    Teng, Yong
    Steuer, Conor E.
    Shin, Dong M.
    Liu, Yuan
    Ahmed, Rafi
    Koyfman, Shlomo A.
    JAMA ONCOLOGY, 2024, 10 (07) : 896 - 904
  • [46] Salvage re-irradiation using intensity-modulated radiotherapy for squamous cell carcinoma of the head and neck
    Chin, R. K.
    Daly, M. E.
    Maxim, P. G.
    Loo, B. W.
    Le, Q. T.
    Chang, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S420 - S420
  • [47] Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
    Wirth, L. J.
    Allen, A. M.
    Posner, M. R.
    Haddad, R. I.
    Li, Y.
    Clark, J. R.
    Busse, P. M.
    Chan, A. W.
    Goguen, L. A.
    Norris, C. M.
    Annino, D. J.
    Tishler, R. B.
    ANNALS OF ONCOLOGY, 2010, 21 (02) : 342 - 347
  • [48] Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory
    Duprez, Frederic
    Madani, Indira
    Bonte, Katrien
    Boterberg, Tom
    Vakaet, Luc
    Derie, Cristina
    De Gersem, Werner
    De Neve, Wilfried
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 563 - 569
  • [49] Phase II Trial of Intensity-Modulated Radiotherapy Concurrent With Chemotherapy for Postoperative Node-Positive Esophageal Squamous Cell Carcinoma
    Tao, Hua
    Zhou, Yiqin
    Yao, Chengyun
    Gu, Dayong
    Chen, Wei
    Lu, Jincheng
    ONCOLOGY RESEARCH, 2017, 25 (08) : 1357 - 1362
  • [50] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
    Bonomo, Pierluigi
    Desideri, Isacco
    Mangoni, Monica
    Saieva, Calogero
    Loi, Mauro
    Becherini, Carlotta
    Cerbai, Cecilia
    Ganovelli, Michele
    Salvestrini, Viola
    Stocchi, Giulia
    Zani, Margherita
    Palomba, Annarita
    Livi, Lorenzo
    RADIOTHERAPY AND ONCOLOGY, 2022, 169 : 64 - 70
12345